Abilify mechanism of action?

How does Abilify work in the brain?

Abilify (aripiprazole) acts on dopamine and serotonin receptors, which helps explain both its antipsychotic effects and its use in mood disorders.[1]

What is its main mechanism at dopamine receptors?

Aripiprazole is a partial agonist at dopamine D2 receptors. That means it can activate D2 signaling when dopamine activity is low, but reduce over-activity when dopamine activity is high, helping rebalance dopamine pathways.[1]

How does it affect serotonin receptors?

Abilify is also a partial agonist at serotonin 5-HT1A receptors and antagonizes (blocks) serotonin 5-HT2A receptors.[1] This dopamine/serotonin receptor pattern contributes to its psychiatric effects and tolerability profile versus drugs with different receptor targets.[1]

Does Abilify work differently from typical antipsychotics?

Yes. Many traditional antipsychotics are stronger dopamine D2 antagonists (they primarily block D2). Abilify’s partial agonist action at D2 receptors is a key mechanistic difference that supports its overall “modulating” role rather than simple blockade.[1]

What does the mechanism imply for patient symptoms?

By modulating dopamine and serotonin signaling (D2 partial agonism plus 5-HT1A partial agonism and 5-HT2A antagonism), aripiprazole can reduce psychosis-related symptoms and help stabilize certain mood symptoms depending on the indication.[1]

Sources:
[1] https://www.drugs.com/mechanism-of-action/abilify-aripiprazole.html